Okamoto Hiroshi | Department of Cardiovascular Medicine, Graduate School of Medicine, Hokkaido University

スポンサーリンク

概要

• Okamoto Hiroshiの詳細を見る
• 同名の論文著者
• Department of Cardiovascular Medicine, Graduate School of Medicine, Hokkaido Universityの論文著者

Department of Cardiovascular Medicine, Graduate School of Medicine, Hokkaido University | 論文

• 1 Pharmacogenomics of β-blocker Therapy in Chronic Heart Failure(New Approaches to Heart Failure-from Pharmacogenomics to Drug Development, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
• Which is most Beneficial for Preserving Cardiac Function and Coronary Microvasculaturein DCM, ACE-I, ARB or Two in Combination? (Cardiac Hypertrophy/Cardiomyopathy 2 (M), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
• Eplerenone Prevents Cardiac Fibrosis through the Inhibition of OPN Expression (Cardiac Hypertrophy, Basic (M), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
• Osteopontin is Essential for Angiotensin II-Induced Cardiac Fibrosis(Heart Failure, Basic 2 (M), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
• A Newly Developed Angiotensin II Type 1 Receptor Antagonist, CS866, Promotes Regression of Cardiac Hypertrophy by Reducing Integrin β_1 Expression

もっと見る

スポンサーリンク